| Species |
HBV |
| Protein Construction |
Hepatitis B Virus (HBV) (ayw/France/Tiollais/1979) Capsid (Met1-Val149)
Accession # P03146-1 |
His |
| N-term |
C-term |
|
| Purity |
> 95% as determined by BisTris PAGE
> 95% as determined by HPLC |
| Endotoxin Level |
Less than 1EU per μg by the LAL method. |
| Expression System |
E.coli |
| Theoretical Molecular Weight |
17.81 kDa |
| Apparent Molecular Weight |
The protein has a predicted MW of 17.81 kDa same as Bis-Tris PAGE result. |
| Formulation |
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). |
| Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
| Target Background |
Hepatitis B virus (HBV) core protein, the building block of the HBV capsid, plays multiple roles in viral replication, and is an attractive target for development of antiviral agents with a new mechanism of action. |
| Synonyms |
Capsid; Core antigen; Core; HBcAg; p21.5; C |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
